S&P 500   3,320.79 (-0.27%)
DOW   29,196.04 (-0.52%)
QQQ   223.28 (-0.04%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
S&P 500   3,320.79 (-0.27%)
DOW   29,196.04 (-0.52%)
QQQ   223.28 (-0.04%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
S&P 500   3,320.79 (-0.27%)
DOW   29,196.04 (-0.52%)
QQQ   223.28 (-0.04%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
S&P 500   3,320.79 (-0.27%)
DOW   29,196.04 (-0.52%)
QQQ   223.28 (-0.04%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
Log in
(Ad)
Located just 25 miles from Cleveland... is a supergreenhouse unlike anything we've ever seen. Listed at over 1.4 million sq ft, (the size of 9 full-sized Costco warehouses), this marijuana grow house is capable of producing over 341,000 pounds of weed/year! And very soon it will come online and could turn a tiny 60-cent pot company into the dominator in the white-hot weed market.

NASDAQ:RCM - R1 RCM Stock Price, Forecast & News

$13.47
+0.05 (+0.37 %)
(As of 01/21/2020 04:00 PM ET)
Today's Range
$13.31
Now: $13.47
$13.79
50-Day Range
$11.75
MA: $12.71
$13.84
52-Week Range
$7.58
Now: $13.47
$13.99
Volume994,061 shs
Average Volume1.10 million shs
Market Capitalization$1.52 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.14
R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers. Read More…

Industry, Sector and Symbol

Industry Management services
Sub-IndustryHealth Care Services
SectorFinance
Current SymbolNASDAQ:RCM
CUSIP00438V10
Phone312-324-7820

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$868.50 million
Cash Flow$0.23 per share
Book Value$0.06 per share

Profitability

Net Income$-45,300,000.00

Miscellaneous

Employees18,600
Market Cap$1.52 billion
Next Earnings Date2/28/2020 (Estimated)
OptionableNot Optionable

Receive RCM News and Ratings via Email

Sign-up to receive the latest news and ratings for RCM and its competitors with MarketBeat's FREE daily newsletter.


R1 RCM (NASDAQ:RCM) Frequently Asked Questions

What is R1 RCM's stock symbol?

R1 RCM trades on the NASDAQ under the ticker symbol "RCM."

How were R1 RCM's earnings last quarter?

R1 RCM Inc (NASDAQ:RCM) issued its quarterly earnings data on Tuesday, November, 5th. The healthcare provider reported $0.01 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.09 by $0.08. The healthcare provider had revenue of $301.20 million for the quarter, compared to analysts' expectations of $302.85 million. R1 RCM had a negative net margin of 0.13% and a positive return on equity of 100.31%. The company's revenue for the quarter was up 20.3% on a year-over-year basis. During the same quarter last year, the company earned ($0.17) earnings per share. View R1 RCM's Earnings History.

When is R1 RCM's next earnings date?

R1 RCM is scheduled to release their next quarterly earnings announcement on Friday, February 28th 2020. View Earnings Estimates for R1 RCM.

What price target have analysts set for RCM?

4 Wall Street analysts have issued 1-year price targets for R1 RCM's shares. Their forecasts range from $14.00 to $17.00. On average, they expect R1 RCM's stock price to reach $15.25 in the next twelve months. This suggests a possible upside of 13.2% from the stock's current price. View Analyst Price Targets for R1 RCM.

What is the consensus analysts' recommendation for R1 RCM?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for R1 RCM.

Has R1 RCM been receiving favorable news coverage?

Media stories about RCM stock have been trending positive this week, according to InfoTrie. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. R1 RCM earned a media sentiment score of 2.2 on InfoTrie's scale. They also assigned news headlines about the healthcare provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for R1 RCM.

Are investors shorting R1 RCM?

R1 RCM saw a increase in short interest during the month of December. As of December 31st, there was short interest totalling 7,780,000 shares, an increase of 17.3% from the December 15th total of 6,630,000 shares. Based on an average trading volume of 1,130,000 shares, the short-interest ratio is presently 6.9 days. Currently, 8.0% of the company's stock are sold short. View R1 RCM's Current Options Chain.

Who are some of R1 RCM's key competitors?

What other stocks do shareholders of R1 RCM own?

Based on aggregate information from My MarketBeat watchlists, some companies that other R1 RCM investors own include Alibaba Group (BABA), NVIDIA (NVDA), Baozun (BZUN), Marvell Technology Group (MRVL), JD.Com (JD), NMI (NMIH), Booz Allen Hamilton (BAH), Skechers USA (SKX), Change Healthcare (CHNG) and Fortinet (FTNT).

Who are R1 RCM's key executives?

R1 RCM's management team includes the folowing people:
  • Mr. Joseph Gerard Flanagan, Pres, CEO & Director (Age 48)
  • Mr. Gary S. Long, Exec. VP & Chief Commercial Officer (Age 49)
  • Mr. Richard B. Evans Jr., Sr. VP, Interim CFO, Corp. Controller & Chief Accounting Officer (Age 51)
  • Mr. Atif A. Rahim, Sr. VP of Investor Relations & Bus. Devel.
  • Mr. Corey Perman, Exec. VP of Compliance & Risk

Who are R1 RCM's major shareholders?

R1 RCM's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Hennessy Advisors Inc. (0.24%), Tealwood Asset Management Inc. (0.19%), Calamos Advisors LLC (0.09%) and FNY Investment Advisers LLC (0.00%). Company insiders that own R1 RCM stock include Albert Rene Zimmerli and Charles J Ditkoff. View Institutional Ownership Trends for R1 RCM.

Which institutional investors are selling R1 RCM stock?

RCM stock was sold by a variety of institutional investors in the last quarter, including Calamos Advisors LLC and Hennessy Advisors Inc.. View Insider Buying and Selling for R1 RCM.

Which institutional investors are buying R1 RCM stock?

RCM stock was purchased by a variety of institutional investors in the last quarter, including Tealwood Asset Management Inc. and FNY Investment Advisers LLC. View Insider Buying and Selling for R1 RCM.

How do I buy shares of R1 RCM?

Shares of RCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is R1 RCM's stock price today?

One share of RCM stock can currently be purchased for approximately $13.47.

How big of a company is R1 RCM?

R1 RCM has a market capitalization of $1.52 billion and generates $868.50 million in revenue each year. The healthcare provider earns $-45,300,000.00 in net income (profit) each year or ($0.32) on an earnings per share basis. R1 RCM employs 18,600 workers across the globe.View Additional Information About R1 RCM.

What is R1 RCM's official website?

The official website for R1 RCM is http://www.r1rcm.com/.

How can I contact R1 RCM?

R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The healthcare provider can be reached via phone at 312-324-7820 or via email at [email protected]


MarketBeat Community Rating for R1 RCM (NASDAQ RCM)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  204 (Vote Outperform)
Underperform Votes:  280 (Vote Underperform)
Total Votes:  484
MarketBeat's community ratings are surveys of what our community members think about R1 RCM and other stocks. Vote "Outperform" if you believe RCM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RCM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel